Literature search services are currently unavailable. During our hosting provider's UPS upgrade we experienced a hardware failure and are currently working to resolve the issue.

Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Caspase 8 inhibits programmed necrosis by processing CYLD.

Caspase 8 initiates apoptosis downstream of TNF death receptors by undergoing autocleavage and processing the executioner caspase 3 (ref. 1). However, the dominant function of caspase 8 is to transmit a pro-survival signal that suppresses programmed necrosis (or necroptosis) mediated by RIPK1 and RIPK3 (refs 2-6) during embryogenesis and haematopoiesis(7-9). Suppression of necrotic cell death by caspase 8 requires its catalytic activity but not the autocleavage essential for apoptosis(10); however, the key substrate processed by caspase 8 to block necrosis has been elusive. A key substrate must meet three criteria: it must be essential for programmed necrosis; it must be cleaved by caspase 8 in situations where caspase 8 is blocking necrosis; and mutation of the caspase 8 processing site on the substrate should convert a pro-survival response to necrotic death without the need for caspase 8 inhibition. We now identify CYLD as a substrate for caspase 8 that satisfies these criteria. Following TNF stimulation, caspase 8 cleaves CYLD to generate a survival signal. In contrast, loss of caspase 8 prevented CYLD degradation, resulting in necrotic death. A CYLD substitution mutation at Asp 215 that cannot be cleaved by caspase 8 switches cell survival to necrotic cell death in response to TNF.

Pubmed ID: 22037414


  • O'Donnell MA
  • Perez-Jimenez E
  • Oberst A
  • Ng A
  • Massoumi R
  • Xavier R
  • Green DR
  • Ting AT


Nature cell biology

Publication Data

December 2, 2011

Associated Grants

  • Agency: NIAID NIH HHS, Id: AI052417
  • Agency: NIAID NIH HHS, Id: AI44828
  • Agency: NIDDK NIH HHS, Id: P30 DK043351
  • Agency: NIAID NIH HHS, Id: R01 AI044828
  • Agency: NIAID NIH HHS, Id: R01 AI044828-13
  • Agency: NIAID NIH HHS, Id: R01 AI052417
  • Agency: NIGMS NIH HHS, Id: R01 GM052735
  • Agency: NIGMS NIH HHS, Id: R01 GM052735-11

Mesh Terms

  • Animals
  • Caspase 8
  • Cell Survival
  • Cells, Cultured
  • Embryo, Mammalian
  • Female
  • Fibroblasts
  • HEK293 Cells
  • Humans
  • Jurkat Cells
  • Mice
  • Necrosis
  • Protein Processing, Post-Translational
  • Signal Transduction
  • Tumor Suppressor Proteins